1 – 15 of 28
- show: 15
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
- Multigene panel testing beyond BRCA1/2 in breast/ovarian cancer Spanish families and clinical actionability of findings (
- 2017
- Clinical management of pancreatic cancer aided by histone signatures (
- 2016
- Cartilage oligomeric matrix protein contributes to the development and metastasis of breast cancer (
- Annexin-A1 and caldesmon are associated with resistance to tamoxifen in estrogen receptor positive recurrent breast cancer (
- Targeted MS Assay Predicting Tamoxifen Resistance in Estrogen-Receptor-Positive Breast Cancer Tissues and Sera (
- The advantage of laser-capture microdissection over whole tissue analysis in proteomic profiling studies (
- 2015
- miR-155, identified as anti-metastatic by global miRNA profiling of a metastasis model, inhibits cancer cell extravasation and colonization in vivo and causes significant signaling alterations (
- 2014
- Associations of hormone replacement therapy and oral contraceptives with risk of colorectal cancer defined by clinicopathological factors, beta-catenin alterations, expression of cyclin D1, p53, and microsatellite-instability (
- Efficient identification of miRNAs for classification of tumor origin (
- Comparative proteome analysis revealing an 11-protein signature for aggressive triple-negative breast cancer (
- Ferritin heavy chain in triple negative breast cancer : a favorable prognostic marker that relates to a cluster of differentiation 8 positive (CD8+) effector T-cell response (
- 2013
- Associations of beta-catenin alterations and MSI screening status with expression of key cell cycle regulating proteins and survival from colorectal cancer (
- Quantitative proteomic analysis of microdissected breast cancer tissues : comparison of label-free and SILAC-based quantification with shotgun, directed, and targeted MS approaches (
- 2012
- A cohort study of the prognostic and treatment predictive value of SATB2 expression in colorectal cancer (
- 2011
- Network analysis of skin tumor progression identifies a rewired genetic architecture affecting inflammation and tumor susceptibility (